Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Portage Biotech Inc. per 2025 Mar 31 adalah -7.42 MM.
- Nilai net income untuk Portage Biotech Inc. per 2025 Mar 31 adalah -6.77 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-03-31 | -7.42 | -6.77 | |
2024-12-31 | -9.20 | -29.78 | |
2024-09-30 | -11.76 | -67.28 | |
2024-06-30 | -16.09 | -71.08 | |
2024-03-31 | -18.25 | -75.34 | |
2023-12-31 | -18.97 | -144.90 | |
2023-09-30 | -18.99 | -113.01 | |
2023-06-30 | -16.70 | -108.80 | |
2023-03-31 | -15.78 | -104.61 | |
2022-12-31 | -16.30 | -17.48 | |
2022-09-30 | -16.41 | -13.51 | |
2022-06-30 | -16.08 | -15.53 | |
2022-03-31 | -15.59 | -16.87 | |
2021-12-31 | -20.32 | -21.05 | |
2021-09-30 | -16.45 | -18.72 | |
2021-06-30 | -14.29 | -18.20 | |
2021-03-31 | -12.24 | -15.83 | |
2020-12-31 | -4.54 | -5.64 | |
2020-09-30 | -5.32 | -5.77 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk Portage Biotech Inc. pada 2025 Mar 31 adalah -5.72.
- laba per saham yang terdilusi untuk Portage Biotech Inc. pada 2025 Mar 31 adalah -5.72.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-03-31 | -5.72 | -5.72 |
2024-12-31 | -26.59 | -26.59 |
2024-09-30 | -63.79 | -63.70 |
2024-06-30 | -70.50 | -70.41 |
2024-03-31 | -77.83 | -77.83 |
2023-12-31 | -157.22 | -157.22 |
2023-09-30 | -129.37 | -129.37 |
2023-06-30 | -126.47 | -126.47 |
2023-03-31 | -129.79 | -129.79 |
2022-12-31 | -23.11 | -23.08 |
2022-09-30 | -19.02 | -18.99 |
2022-06-30 | -23.28 | -23.27 |
2022-03-31 | -25.83 | -25.80 |
2021-12-31 | -33.04 | -33.05 |
2021-09-30 | -30.16 | -30.17 |
2021-06-30 | -30.31 | -30.35 |
2021-03-31 | -26.99 | -27.00 |
2020-12-31 | -9.84 | -9.90 |
2020-09-30 | -10.30 | -10.36 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Portage Biotech Inc. per 2025 Mar 31 adalah -5.46 MM.
- Nilai kas dari aktivitas pendanaan untuk Portage Biotech Inc. per 2025 Mar 31 adalah 2.10 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-03-31 | -5.46 | 2.10 | |
2024-12-31 | -7.47 | 2.81 | 1.04 |
2024-09-30 | -9.80 | 2.81 | 5.30 |
2024-06-30 | -12.53 | 2.81 | 5.35 |
2024-03-31 | -14.30 | 2.81 | 5.97 |
2023-12-31 | -15.86 | 0.00 | 8.09 |
2023-09-30 | -15.13 | 0.00 | 3.54 |
2023-06-30 | -13.35 | -0.62 | 0.49 |
2023-03-31 | -12.07 | -0.62 | -0.12 |
2022-12-31 | -9.64 | -0.62 | -2.24 |
2022-09-30 | -8.60 | -0.62 | -3.01 |
2022-06-30 | -7.36 | -0.08 | |
2022-03-31 | -6.76 | 27.35 | |
2021-12-31 | -5.43 | 0.00 | 27.40 |
2021-09-30 | -4.57 | 0.00 | 27.40 |
2021-06-30 | -5.18 | 0.14 | 25.46 |
2021-03-31 | -4.28 | -0.86 | 4.76 |
2020-12-31 | -4.21 | -0.86 | 5.71 |
2020-09-30 | -4.07 | -0.86 | 5.51 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-03-31 | ||
2024-12-31 | ||
2024-09-30 | ||
2024-06-30 | ||
2024-03-31 | ||
2023-12-31 | ||
2023-09-30 | ||
2023-06-30 | ||
2023-03-31 | ||
2022-12-31 | ||
2022-09-30 | ||
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-03-31 | |||||
2024-12-31 | |||||
2024-09-30 | |||||
2024-06-30 | |||||
2024-03-31 | |||||
2023-12-31 | |||||
2023-09-30 | |||||
2023-06-30 | |||||
2023-03-31 | |||||
2022-12-31 | |||||
2022-09-30 | |||||
2022-06-30 | |||||
2022-03-31 | |||||
2021-12-31 | |||||
2021-09-30 | |||||
2021-06-30 | |||||
2021-03-31 | |||||
2020-12-31 | |||||
2020-09-30 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1095435 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |